Life Goal Wealth Advisors Eli Lilly & CO Transaction History
Life Goal Wealth Advisors
- $92.2 Billion
- Q4 2024
A detailed history of Life Goal Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Life Goal Wealth Advisors holds 281 shares of LLY stock, worth $232,125. This represents 0.24% of its overall portfolio holdings.
Number of Shares
281Holding current value
$232,125% of portfolio
0.24%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,091Shares Held
737MCall Options Held
8.26MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$80 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$60.9 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$54.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$42.4 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$28 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $785B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...